Celltech Biologics Inc., a subsidiary of the U.K.-based CelltechGroup plc, announced last week that it will build amanufacturing facility at New Hampshire's Pease InternationalTradeport.
As part of New Hampshire's redevelopment of the formerPease Air Force Base, the Pease Development Authority (PDA)will provide $30 million to finance the construction andequipping of the 43,000 square foot biotechnologymanufacturing facility, while Celltech will contribute $2 millionfor preparing the site for construction.
The U.K. monoclonal antibody-manufacturing company has alsoguaranteed at least 100 jobs once the facility is fully functional.
(c) 1997 American Health Consultants. All rights reserved.